Viewing Study NCT01172392


Ignite Creation Date: 2025-12-24 @ 3:21 PM
Ignite Modification Date: 2026-01-06 @ 9:24 PM
Study NCT ID: NCT01172392
Status: UNKNOWN
Last Update Posted: 2013-03-29
First Post: 2010-07-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B
Sponsor: ANRS, Emerging Infectious Diseases
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module